Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study

作者:Grammatico Sara; Bringhen Sara; Vozella Federico; Siniscalchi Agostina; Boccadoro Mario; Petrucci Maria Teresa*
来源:Leukemia and Lymphoma, 2017, 58(11): 2738-2740.
DOI:10.1080/10428194.2017.1307360